Skip to main content
Drug bottle and Pill

Compare Rinvoq vs. Humira

Head-to-head comparisons of medication uses, side effects, warnings, and more.

Key takeaways

Rinvoq (upadacitinib) and Humira (adalimumab) are both medications used to treat inflammatory conditions like rheumatoid arthritis (RA) and Crohn's disease (CD). However, they belong to different medication classes. Rinvoq is a Janus kinase (JAK) inhibitor, while Humira is a biologic disease-modifying antirheumatic drug (DMARD) that blocks tumor necrosis factor (TNF). Rinvoq is taken orally, usually once a day, and is available as an extended-release tablet and an oral solution. In contrast, Humira is injected under the skin, typically every other week, and is available as a prefilled injection pen. Common side effects of Rinvoq include a higher risk of infections and acne, while Humira can cause injection-site reactions and upper respiratory infections. Both medications can increase the risk of serious infections, but they have different interactions and precautions, such as avoiding grapefruit with Rinvoq and caution with live vaccines with Humira.

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.